anti-Crotonaldehyde [CRA], mAb (82D3)
Code | Size | Price |
---|
JAI-MCA-030N-30ug | 30 ug | £1,164.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Isotype: Mouse IgG2a
Antibody Clonality: Monoclonal
Antibody Clone: 82D3
Regulatory Status: RUO
Target Species: Human
Application: Immunohistochemistry (IHC)
Shipping:
BLUE ICE
Storage:
-20°C
Documents
Further Information
EClass:
32160000
Form (Short):
liquid
Formulation:
Frozen liquid. Contains 10mM PBS, 0.1% NaN3 and 0.5% BSA.
Handling Advice:
Avoid freeze/thaw cycles.
Immunogen:
CRA-modified keyhole-lympet hemocyanine.
Long Description:
Monoclonal Antibody. Recognizes CRA-modified proteins (especially CRA-lysine adducts). Frozen liquid. Contains 10mM PBS, 0.1% NaN3 and 0.5% BSA. Crotonaldehyde (CRA) is a representative carcinogenic aldehyde formed endogenously through lipid peroxidation. CRA is highly reactive aldehyde and reacts with lysine residue in protein. The reaction with CRA and lysine residue leads to the formation of numerous numbers of adducts.
Package Type:
Plastic Vial
Product Description:
Crotonaldehyde (CRA) is a representative carcinogenic aldehyde formed endogenously through lipid peroxidation. CRA is highly reactive aldehyde and reacts with lysine residue in protein. The reaction with CRA and lysine residue leads to the formation of numerous numbers of adducts.
Specificity:
Recognizes CRA-modified proteins (especially CRA-lysine adducts).
Transportation:
Non-hazardous
UNSPSC Category:
Primary Antibodies
UNSPSC Number:
12352203
Use & Stability:
Stable for at least 3 years after receipt when stored at -20°C.
References
Endogenous formation of protein adducts with carcinogenic aldehydes: K. Ichihashi, et al.; J. Biol. Chem. 276, 23903 (2001)
Related Products
Product Name | Product Code | Supplier | anti-Acrolein [ACR], mAb (5F6) | JAI-MAR-020N | JaICA | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
anti-Acrolein [ACR], mAb (5F6) | JAI-MAR-100N | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
anti-Dibromo-tyrosine [DiBrY], mAb (3A5) | JAI-MBY-020P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
anti-Dityrosine [DT], mAb (1C3) | JAI-MDT-020P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
anti-4-Hydroxy-2-hexenal [4-HHE], mAb (HHE53) | JAI-MHH-030N | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
anti-Hexanoyl-Lys [HEL], mAb (5F12) | JAI-MHL-021P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||